Home About Press Employ Contact Spyglass Advanced Search
HHMI Logo
HHMI News
HHMI News
Scientists & Research
Scientists & Research
Janelia Farm
Janelia Farm
Grants & Fellowships
Grants & Fellowships
Resources
Resources
  Scientists & Research
  Overview  
dashed line
  FindSci  
dashed line
Scientific Competitions
dashed line
HHMI Investigators
dashed line
  JFRC Scientists  
dashed line
  Internatinal Scholars  
dashed line
  Profs  
dashed line
  Nobel Laureates  

HHMI-NIH Research Scholars
Learn about the HHMI-NIH Research Scholars Program, also known as the Cloister Program. Moresmall arrow

dashed line

Janelia Farm Research Campus
Learn about the new HHMI research campus located in Virginia. Moresmall arrow

T Cell Development and Function


Summary: Michael Bevan studies T lymphocyte development, homeostasis, and function, asking what are the signals required during an infection to drive the differentiation of CD8+ cytotoxic T lymphocytes into long-lived memory cells that provide protection against a subsequent encounter with the pathogen.

T cells recognize foreign antigens as peptide fragments presented in the groove of major histocompatibility complex (MHC)-encoded molecules expressed on the cell surface. Cytotoxic T cells, the CD8+ subset of T lymphocytes, recognize and kill cells expressing foreign peptides derived from infection with viruses or intracellular bacteria, or from self-proteins that are overexpressed or mutated in tumors. An elaborate system has evolved to allow peptides generated by proteasomes in the cell cytosol to cross the endoplasmic reticulum membrane and to load onto newly synthesized MHC class I molecules. The stable peptide/MHC complex traffics to the cell surface, thus exposing even intracellular antigens to immune surveillance by the cytotoxic T cell arm of our immune defenses. The CD4+ subset of T lymphocytes recognizes forms of antigen that have been taken up and processed in phagosomes and presented in the groove of MHC class II molecules. On antigen recognition these cells can activate other inflammatory cells, such as macrophages or dendritic cells, and help the response of B lymphocytes and CD8+ T lymphocytes to antigen.

Following an acute infection with certain viruses or bacteria, T cells specific for antigens encoded by the pathogen may go through 15 or more cell divisions within 6 days to produce enormous numbers of effector cells at the peak of the response. When antigen is cleared, more than 90 percent of these effector cells die, leaving behind a population of memory cells that can maintain their numbers for the lifetime of the animal. Memory T cells, which can respond faster to antigen rechallenge than naive T cells, are dispersed in all tissues to deal rapidly with reentry of a pathogen.

How do CD4+ T cells help the response of CD8+ T cells? It was thought that helper T cells and cytotoxic T cells were brought close together by recognizing their antigen on the same cell, and that help was provided by cell-cell contact or the short-range provision of cytokines. More recently, this model has been replaced by one that posits that the antigen-presenting cell (most likely a dendritic cell) is the essential go-between for CD4-mediated assistance in the cytotoxic T cell response. In this model, CD4+ T cells, recognizing antigen, send signals to the presenting cell, thereby activating or "licensing" it to be competent to stimulate the CD8 response. Without CD4 activation, the presenting cell would be unable to stimulate CD8+ T cells. This idea fit nicely with the knowledge that cytotoxic T cell responses to weak antigens, such as tumor cells, are CD4 dependent, while responses to viruses or bacteria, which can themselves activate dendritic cells, are CD4 independent. It was a surprise then when we showed that even though the primary CD8 response to the intracellular bacterial pathogen Listeria monocytogenes, which has a plethora of immune system alarm signals, is CD4 independent, the secondary or memory CD8 response wanes in the absence of CD4+ T cells. Memory appears to be CD4 dependent.

CD4+ T cells do more than simply activate the presenting cell. We found that memory CD8+ T cells primed and maintained in the absence of CD4 cells actually decrease in number compared to controls, and the survivors lose functionality, such as the ability to respond rapidly to a second antigen challenge. Other groups have suggested that CD4+ T cells must "program" the CD8+ T cell to be able to produce long-lived protective memory cells when the initial infection has been cleared. Our data indicate, however, that even when antigen is cleared, memory CD8+ T cells still require CD4 T cells for their maintenance. We found that when memory T cells from a control animal are isolated and transferred back into control or CD4-deficient animals, they fade away in the latter environment. We are investigating the basis for this trophic function of CD4+ T cells for memory cytotoxic T cells. Interleukin-7 (IL-7) and IL-15, cytokines that are normally associated with memory T cell maintenance, are not reduced in the lymphoid tissues of animals lacking CD4+ T cells. Our recent evidence suggests that IL-2, perhaps produced by CD4 cells, may be a key factor in the early programming of memory differentiation. CD8+ T cells that respond to pathogen challenge without also receiving signals from IL-2 expand as usual and make memory cells, but these "unhelped" memory cells die on rechallenge with the pathogen. IL-2 signals are not required to promote the growth of CD8+ T cells responding to an infection, but they are required to push their complete differentiation to functional memory cells.

To avoid autoimmunity, the immune system must maintain self-tolerance. This begins in the thymus when T cells with dangerously high affinity for self-antigen are deleted in a process referred to as central tolerance. How peripheral self-antigens, which are not supposed to be present in the thymus, could be represented in this negative-selection screen has been a mystery. Amazingly, many tissue-specific antigens are ectopically, or promiscuously, expressed in the thymus to mediate central tolerance. Epithelial cells in the medulla of the thymus express pancreatic, adrenal, and ocular antigens, and this ectopic expression leads to the deletion of newly arising T cells that could damage these peripheral targets. Humans and mice that lack this ectopic expression of tissue-specific antigen in the thymus succumb to multiorgan inflammation and autoimmune disease.

In a system in which the insulin promoter is used to drive expression of a model antigen in the islet of Langherhans as well as ectopically in the thymus medulla, we have studied the efficiency and cellular requirements for the negative selection of CD4+ and CD8+ T cells in the thymus. The results show that the most effective presentation of antigen for deletion in the thymus medulla is performed not by the cells making antigen, but by professional antigen-presenting cells, probably dendritic cells, that acquire antigen from the medullary epithelial cells and “cross-present” it to developing T cells. How the professional antigen presenters do this—whether by phagocytosis of dying medullary cells or via uptake of membrane blebs from healthy cells—is not known. T cells bearing receptors with high affinity for the self-antigen are efficiently deleted. We find, however, that below a certain threshold of affinity, self-reactive T cells escape the thymus and populate the peripheral lymphoid organs. Under normal conditions, these cells are harmless. But when they are activated following infection by a pathogen that introduces a cross-reactive antigen, or higher levels of the self-antigen, autoimmunity can result. As effector cells, these weakly autoreactive T cells can cause autoimmune tissue damage, such as destruction of pancreatic islets resulting in diabetes.

Part of this work is supported by a grant from the National Institutes of Health.

Last updated: July 17, 2007

HHMI INVESTIGATOR

Michael J. Bevan
Michael J. Bevan
 

Related Links

ON THE WEB

external link icon

The Bevan Lab
(washington.edu)

search icon Search PubMed
dashed line
 Back to Topto the top
HHMI Logo

Home | About HHMI | Press Room | Employment | Contact

© 2008 Howard Hughes Medical Institute. A philanthropy serving society through biomedical research and science education.
4000 Jones Bridge Road, Chevy Chase, MD 20815-6789 | (301) 215-8500 | e-mail: webmaster@hhmi.org